Taro 2002 News Archive

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

2/13/2002

Taro to Report Results and Conduct Conference Call on February 21, 2002

Hawthorne, NY, February 13, 2002 – Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS: TARO) today reported that the Company intends to announce financial results for the fourth quarter and full year ended December 31, 2001, prior to the Nasdaq market opening on Thursday, February 21, 2002. The Company will conduct a conference call to discuss the results on the same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time).

The conference call will be hosted by Barrie Levitt, M.D., Chairman of the Company, who will review the quarter and the year along with Kevin Connelly, Chief Financial Officer, and Daniel Saks, Vice President, Corporate Affairs. The call will be available live via the Internet by accessing www.taro.com. For those who cannot listen to the live broadcast, an online replay will be available through February 27, 2002, on www.taro.com. A telephone replay will be available through February 27, 2002, by dialing 800-428-6051 (domestic U.S.) or 973-709-2089 (international) and entering the passcode 231333 when prompted.

Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

###